Danna Liu, CPA, currently serves as Assistant Controller at BridgeBio Oncology Therapeutics (BBOT), a biotech company focused on cancer drug development, since January 2025. Prior to this, Danna held the position of Associate Director of Financial Reporting at FibroGen, Inc. from February 2020 to November 2024, contributing to a biopharmaceutical firm dedicated to addressing serious unmet medical needs. Danna's experience also includes managerial roles in financial reporting at Walmart between January 2016 and January 2020, as well as accounting positions at TubeMogul, Inc., International Asset Systems, and CrowdFlower Inc. Danna holds a Master of Science in Accounting from Golden Gate University and a Bachelor's degree in Business/Managerial Economics from the University of California, Davis.